Exposure to rhodamine B (RhB), a toxic fluorescent dye, causes neurodegeneration, symptoms that resemble ALS, and molecular ...

Far-field potentials (FFPs), nerve signals that can be measured on the skin, show promise as diagnostic and prognostic ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Completing a project in her backyard was satisfying for columnist Kristin Neva, whose work as an ALS caregiver is repetitive and ongoing.

In ALS, the loss of certain proteins turns off a gene called UNC13A that needs to stay active for nerve cell communication, a ...

Columnist Dagmar Munn feels as if she's finding her voice again as she picks up her speech exercises, and then some.

Patient randomization is nearly complete in Medicinova’s Phase 2b/3 COMBAT-ALS trial testing MN-166 (ibudilast) for the ...

Patient randomization is nearly complete in Medicinova’s Phase 2b/3 COMBAT-ALS trial testing MN-166 (ibudilast) for the treatment of ALS.

Answer ALS is backing a Louisiana collaboration aimed at using AI to accelerate drug discovery for ALS and other ...